Union Commerce Minister Piyush Goyal defended India's intellectual property rights during a press meeting with Swiss ...

India's Commerce Minister refutes claims of Indian pharma firms copying products, highlighting India's respect for ...

Goyal positioned India's approach as protecting the rights of both innovators and consumers, arguing that companies should be able to recover their research and development investments during the ...

The ministry has earlier criticised attempts by certain firms to secure pharmaceutical patents through minor incremental ...

Responding to media questions in Bern, Goyal termed the claims as “myths” with no factual basis. “Show me one instance where we have illegally copied any trademarks, patents, or copyrighted technology ...

India’s offer comes in the backdrop of the US administration’s stated desire to sharply reduce local drug prices, and gains ...

Piyush Goyal announced India's plan to launch a scheme supporting MSMEs in registering products overseas, aiming to boost ...

Patent and trademark enforcement has become an important economic tool for entrepreneurs.

Pharmaceutical companies also use tactics such as evergreening, where they make minor changes to extend patent lives to prolong exclusivity and high prices. A generic drug is similar to a branded ...

India has offered to supply complex generics at just 20–25 percent of the branded drug prices for the first three years after ...